LASIK vs LASEK vs PRK: advantages and indications
- PMID: 12759854
- DOI: 10.1076/soph.18.1.2.14074
LASIK vs LASEK vs PRK: advantages and indications
Abstract
The advent of the excimer laser as an instrument for use in reshaping the corneal stroma was a great step forward in refractive surgery. Laser energy can be delivered on the stromal surface in the photorefractive keratectomy (PRK) procedure or deeper on the corneal stroma by the means of a lamellar surgery in which a flap is created with the microkeratome in the laser in situ keratomileusis (LASIK) procedure. LASIK is currently the dominant procedure in refractive surgery. The main advantage of LASIK over PRK is related to maintaining the central corneal epithelium. This increases comfort during the early post-operative period, allows for rapid visual recovery, and reduces the wound healing response. Reduced wound healing correlates with less regression for high corrections and a lower rate of complications such as significant stromal opacity (haze). PRK, however, remains as an excellent option for mild to moderate corrections, particularly for cases associated with thin corneas, recurrent erosions, or a predisposition for trauma (Martial arts, military, etc.). Recently, a modification of PRK, laser subepithelial keratomileusis (LASEK), was introduced. In the LASEK procedure, an epithelial flap is created and replaced after the ablation. The benefits, if any, of the creation of an epithelial flap compared to traditional PRK are not fully appreciated. Advocates of LASEK suggest that there is less discomfort in the early postoperative period, faster visual recovery, and less haze compared to standard PRK for correction of similar levels of refractive error. Additional long-term clinical studies, along with laboratory research, will be crucial to validate these potential advantages of LASEK procedure.
Similar articles
-
Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.J Cataract Refract Surg. 2007 Dec;33(12):2041-8. doi: 10.1016/j.jcrs.2007.07.026. J Cataract Refract Surg. 2007. PMID: 18053901
-
Laser-assisted subepithelial keratectomy for myopia: two-year follow-up.J Cataract Refract Surg. 2003 Apr;29(4):661-8. doi: 10.1016/s0886-3350(02)01897-7. J Cataract Refract Surg. 2003. PMID: 12686232 Clinical Trial.
-
A randomized prospective clinical trial comparing laser subepithelial keratomileusis and photorefractive keratectomy.Arch Ophthalmol. 2004 Jan;122(1):11-6. doi: 10.1001/archopht.122.1.11. Arch Ophthalmol. 2004. PMID: 14718288 Clinical Trial.
-
LASEK (laser subepithelial keratomileusis).Curr Opin Ophthalmol. 2002 Aug;13(4):261-3. doi: 10.1097/00055735-200208000-00014. Curr Opin Ophthalmol. 2002. PMID: 12165712 Review.
-
Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature.Surv Ophthalmol. 2004 Nov-Dec;49(6):576-602. doi: 10.1016/j.survophthal.2004.08.003. Surv Ophthalmol. 2004. PMID: 15530945 Review.
Cited by
-
Validation of the Arabic version of the quality of life impact of refractive correction questionnaire.Saudi J Ophthalmol. 2022 Jul 11;36(1):83-89. doi: 10.4103/sjopt.sjopt_117_21. eCollection 2022 Jan-Mar. Saudi J Ophthalmol. 2022. PMID: 35971486 Free PMC article.
-
Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes.PLoS One. 2021 Dec 7;16(12):e0259993. doi: 10.1371/journal.pone.0259993. eCollection 2021. PLoS One. 2021. PMID: 34874947 Free PMC article.
-
Laser-Assisted In Situ Keratomileusis (LASIK) Enhancement for Residual Refractive Error after Primary LASIK.J Clin Med. 2022 Aug 18;11(16):4832. doi: 10.3390/jcm11164832. J Clin Med. 2022. PMID: 36013070 Free PMC article.
-
Computational study for temperature distribution in ArF excimer laser corneal refractive surgeries using different beam delivery techniques.Lasers Med Sci. 2022 Apr;37(3):1709-1716. doi: 10.1007/s10103-021-03420-z. Epub 2021 Sep 26. Lasers Med Sci. 2022. PMID: 34564765
-
SMAD4-Dependent Signaling Pathway Involves in the Pathogenesis of TGFBR2-Related CE-like Phenotype.Cells. 2024 Apr 4;13(7):626. doi: 10.3390/cells13070626. Cells. 2024. PMID: 38607065 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources